An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer: Continued Avastin Plus Chemotherapy After First Progression in Clinical Practice
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 07 Jun 2017
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Roche
- 29 May 2017 Status changed from recruiting to active, no longer recruiting.
- 04 Nov 2016 Planned End Date changed from 1 Dec 2016 to 1 Jun 2017.
- 04 Nov 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jun 2017.